FDA Approves Risperdal for Kids

The Food and Drug Administration has approved the use of the powerful antipsychotic drug Risperdal for use in preteens and teenagers with schizophrenia or manic depressive illness. Risperdal can be very effective, but it also has some significant side effects.

American Psychiatric Association President Carolyn Robinowitz, M.D., who has been taking care of adults and children with serious psychiatric disorders for nearly 40 years, speaks with Renee Montagne.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.